美国全国范围内胎盘植入谱系疾病患者分娩时孕周分布评估
该研究基于2016至2021年美国全国住院患者样本中26,375例胎盘植入谱系疾病(PAS)住院分娩,描述其分娩孕周分布及相关产科特征。56.9%的PAS患者早产,43.1%足月分娩;足月分娩者阴道分娩比例更高、前置胎盘及植入/穿透型比例更低,出血、输血、休克、凝血障碍、子宫切除、泌尿道损伤及孕产妇死亡发生率均低于早产者。PAS编码发生率6年间从每10万住院分娩114.8升至132.5,增加15.4%。
要点
- PAS患者中56.9%早产(<37周),43.1%足月分娩(≥37周)。
- 足月PAS者阴道分娩率32.0% vs 早产者6.9%,前置胎盘9.3% vs 50.5%。
- 足月PAS者子宫切除率25.6% vs 早产者65.3%,孕产妇死亡0.0% vs 0.2%。
核心结论
- 在美国全国性横断面研究中,近40%的PAS患者足月分娩,其临床特征和结局与早产PAS患者不同。
- PAS全国发生率持续上升,需要关注和评估。
研究设计与样本
- 系列横断面研究,分析2016至2021年美国医疗保健研究与质量局医疗成本与利用项目全国住院患者样本中26,375例有PAS诊断编码的住院分娩。
- 在21,212,493例住院分娩中评估PAS编码发生率,并进行描述性分析。
主要发现
- PAS患者中56.9%早产(<37周),43.1%足月(≥37周)。
- 足月PAS者较早产PAS者更可能阴道分娩(32.0% vs 6.9%)、在农村医院(9.7% vs 2.3%)或小床位容量医院(18.6% vs 8.4%)分娩,较少有前置胎盘(9.3% vs 50.5%)和植入/穿透亚型(8.6% vs 27.4%),均P<.001。
- 足月PAS者较早产PAS者出血或输血或两者兼有(62.9% vs 71.5%)、休克或凝血障碍或两者兼有(6.2% vs 9.8%)、子宫切除(25.6% vs 65.3%)、泌尿道损伤(2.5% vs 10.0%)及孕产妇死亡(0.0% vs 0.2%)发生率更低,均P<.001。
- 每804例分娩患者中1例有PAS诊断;发生率从早产期每83-300例住院分娩1例降至37周后每705-3,037例住院分娩1例。
- PAS发生率6年间从每10万住院分娩114.8升至132.5,增加15.4%(95%CI,10.7-20.4),P趋势<.001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the distribution of gestational age at delivery for patients with placenta accreta spectrum (PAS) in the United States. METHODS: This serial cross-sectional study examined 26,375 hospital deliveries with a diagnosis code for PAS identified in the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project National Inpatient Sample from 2016 to 2021. Descriptive analysis was performed to evaluate the distribution of gestational age at delivery of patients with PAS and related obstetric characteristics. The incidence of PAS codes was also assessed among 21,212,493 hospital deliveries. RESULTS: The majority of patients with PAS delivered preterm (before 37 weeks of gestation, 56.9%); 43.1% delivered at term (37 weeks of gestation or more). Compared with patients with PAS who had preterm deliveries, those with PAS who had term deliveries were more likely to deliver vaginally (32.0% vs 6.9%) and in a rural-setting (9.7% vs 2.3%) or small-bed-capacity (18.6% vs 8.4%) hospital and were less likely to have placenta previa (9.3% vs 50.5%) and increta and percreta subtypes (8.6% vs 27.4%) (all P <.001). Incidences of hemorrhage or blood transfusion or both (62.9% vs 71.5%), shock or coagulopathy or both (6.2% vs 9.8%), hysterectomy (25.6% vs 65.3%), urinary tract injury (2.5% vs 10.0%), and maternal mortality (0.0% vs 0.2%) were lower for patients with PAS who had term compared with preterm deliveries (all P <.001). When any hospital deliveries were included in the analysis, 1 in every 804 delivering patients had a diagnosis of PAS. The incidence sharply decreased from 1 in 83-300 hospital deliveries in the preterm period to 1 in 705-3,037 hospital deliveries after 37 weeks of gestation. The incidence of PAS increased by 15.4% (95% CI, 10.7-20.4), from 114.8 to 132.5 per 100,000 hospital deliveries during the 6-year study period ( P trend<.001). CONCLUSION: In this nationwide, cross-sectional study in the United States, nearly 40% of patients with PAS delivered at term and had distinct clinical and obstetric characteristics and outcomes compared with patients with PAS who delivered preterm. Continued increase in the incidence of PAS at the national level calls for attention and evaluation.
引用
- Matsuo K, Einerson BD, Matsuzaki S, et al. Nationwide Assessment of Gestational Age Distribution at Delivery for Patients With Placenta Accreta Spectrum Disorder. Obstet Gynecol. 2025. PMID: 39977860. doi:10.1097/AOG.0000000000005849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。